Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Capital Expenditures (2016 - 2023)

Historic Capital Expenditures for Cellectis (CLLS) over the last 9 years, with Q4 2023 value amounting to $1.9 million.

  • Cellectis' Capital Expenditures fell 5769.23% to $1.9 million in Q4 2023 from the same period last year, while for Dec 2023 it was $1.1 million, marking a year-over-year decrease of 5586.18%. This contributed to the annual value of $2.6 million for FY2024, which is 14072.69% up from last year.
  • Cellectis' Capital Expenditures amounted to $1.9 million in Q4 2023, which was down 5769.23% from -$314000.0 recorded in Q3 2023.
  • Cellectis' Capital Expenditures' 5-year high stood at $72.3 million during Q4 2020, with a 5-year trough of -$14.0 million in Q2 2020.
  • For the 5-year period, Cellectis' Capital Expenditures averaged around $4.0 million, with its median value being -$770500.0 (2022).
  • Over the last 5 years, Cellectis' Capital Expenditures had its largest YoY gain of 22506.31% in 2019, and its largest YoY loss of 44428.31% in 2019.
  • Quarter analysis of 5 years shows Cellectis' Capital Expenditures stood at $23.2 million in 2019, then surged by 211.78% to $72.3 million in 2020, then crashed by 49.11% to $36.8 million in 2021, then tumbled by 87.99% to $4.4 million in 2022, then tumbled by 57.69% to $1.9 million in 2023.
  • Its Capital Expenditures was $1.9 million in Q4 2023, compared to -$314000.0 in Q3 2023 and -$270000.0 in Q2 2023.